Abstract
Pluripotent cells are a powerful tool for regenerative medicine and drug discovery. Several techniques have been developed to induce pluripotency, or to extract pluripotent cells from different tissues and biological fluids. However, the characterization of pluripotency requires tedious, expensive, time-consuming, and not always reliable wet-lab experiments; thus, an easy, standard quality-control protocol of pluripotency assessment remains to be established. Here to help comes the use of high-throughput techniques, and in particular, the employment of gene expression microarrays, which has become a complementary technique for cellular characterization. Research has shown that the transcriptomics comparison with an Embryonic Stem Cell (ESC) of reference is a good approach to assess the pluripotency. Under the premise that the best protocol is a computer software source code, here I propose and explain line by line a software protocol coded in R-Bioconductor for pluripotency assessment based on the comparison of transcriptomics data of pluripotent cells with an ESC of reference. I provide advice for experimental design, warning about possible pitfalls, and guides for results interpretation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The directory separator is / or \ for Linux or Windows operating system, respectively.
- 2.
The parameter pos is a position specifier for the text. If specified this overrides any adj value given. Values of 1, 2, 3, and 4, respectively, indicate positions below, to the left of, above, and to the right of the specified coordinates.
References
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313–317
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917–1920
Kang L, Wu T, Tao Y, Yuan Y, He J, Zhang Y, Luo T, Kou Z, Gao S (2010) Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation. Cell Res 21(3):546–549
Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo MJ, Ruau D, Han DW, Zenke M, Schöler HR (2008) Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454(7204):646–650
Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR (2009) Direct reprogramming of human neural stem cells by OCT4. Nature 461(7264):649–653
Feng B, Jiang J, Kraus P, Ng JH, Heng JCD, Chan YS, Yaw LP, Zhang W, Loh YH, Han J et al (2009) Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 11(2):197–203
Chen J, Liu J, Yang J, Chen Y, Chen J, Ni S, Song H, Zeng L, Ding K, Pei D (2010) Bmps functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res 21(1):205–212
Moon JH, Heo JS, Kim JS, Jun EK, Lee JH, Kim A, Kim J, Whang KY, Kang YK, Yeo S et al (2011) Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. Cell Res 21(9):1305–1315
Maekawa M, Yamaguchi K, Nakamura T, Shibukawa R, Kodanaka I, Ichisaka T, Kawamura Y, Mochizuki H, Goshima N, Yamanaka S (2011) Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474(7350):225–229
Heng JCD, Feng B, Han J, Jiang J, Kraus P, Ng JH, Orlov YL, Huss M, Yang L, Lufkin T et al (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6(2):167–174
Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, Egli D, Loh KM et al (2009) A small-molecule inhibitor of TGF-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5(5):491–503
Ko K, Tapia N, Wu G, Kim JB, Araúzo-Bravo MJ, Sasse P, Glaser T, Ruau D, Han DW, Greber B, Hausdölrfer K, Sebastiano S, Stehling M, Fleischmann BK, Brülstle O, Zenke M, Schöller HR (2009) Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell 5(1):87–96
Singhal N, Graumann J, Wu G, Araúzo-Bravo MJ, Han DW, Greber B, Gentile L, Mann M, Schöler HR (2010) Chromatin-remodeling components of the Baf complex facilitate reprogramming. Cell 141(6):943–955
Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S et al (2010) Vitamin c enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6(1):71–79
Liang G, He J, Zhang Y (2012) Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol 14(5):457–466
Han J, Yuan P, Yang H, Zhang J, Soh BS, Li P, Lim SL, Cao S, Tay J, Orlov YL et al (2010) Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463(7284):1096–1100
Hirata T, Amano T, Nakatake Y, Amano M, Piao Y, Hoang HG, Ko MSH (2012) Zscan4 transiently reactivates early embryonic genes during the generation of induced pluripotent stem cells. Sci Rep 2
Zhao X, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo C, Ma Q, Wang L et al (2009) ips cells produce viable mice through tetraploid complementation. Nature 461(7260):86–90
In stem cell information. http://stemcells.nih.gov/research/registry/pluripotent_faq/. Accessed September 13, 2012
Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA et al (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27(11):1033–1037
Ko K, Araúzo-Bravo MJ, Tapia N, Kim J, Lin Q, Bernemann C, Han DW, Gentile L, Reinhardt P, Greber B, Schneider RK, Kliesch S, Zenke M, Schöller HR (2010) Human adult germline stem cells in question. Nature 465(7301):E1-E1
Tapia N, Araúzo-Bravo MJ, Ko K, Schöler HR (2011) Concise review: challenging the pluripotency of human testis-derived esc-like cells. Stem Cells 29(8):1165–1169
Ko K, Reinhardt P, Tapia N, Schneider RK, Araúzo-Bravo MJ, Han DW, Greber B, Kim J, Kliesch S, Zenke M, Schöler HR (2011) Brief report: evaluating the potential of putative pluripotent cells derived from human testis. Stem Cells 29(8):1304–1309
Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J et al (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1):111–123
Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD (2011) Reference maps of human es and ips cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3):439–452
Ruiz S, Diep D, Gore A, Panopoulos AD, Montserrat N, Plongthongkum N, Kumar S, Fung HL, Giorgetti A, Bilic J, Batchelder EM, Zaehres H, Kan NG, Schöler HR, Mercola M, Zhang K, Izpisua Belmonte JC (2012) Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. Proc Natl Acad Sci U S A 109:16196–16201
Guenther MG, Frampton GM, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R, Young RA (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7(2):249–257
Chin MH, Pellegrini M, Plath K, Lowry WE (2010) Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7(2):263–269
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Smith AG (2001) Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17:435–462
Brons I, Smithers L, Trotter M, Gunn PR, Sun B, de Sousa S, Howlett S, Clarkson A, Richter LA, Pedersen R, Vallier L (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191–195
Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RDG (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448(7150):196–199
Nichols J, Smith AG (2009) Naive and primed pluripotent states. Cell Stem Cell 4:487–492
Guo G, Yang J, Nichols J, Hall JS, Eyres I, Manseld W, Smith A (2009) Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136(7):1063–1069
Vallier L, Touboul T, Chng Z, Brimpari M, Hannan N, Millan E, Smithers LE, Trotter M, Rugg-Gunn P, Weber A, Pedersen RA (2009) Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 4(6):e6082
Han DW, Tapia N, Joo JY, Greber B, Araúzo-Bravo MJ, Bernemann C, Ko K, Wu G, Stehling M, Do JT, Schöler HR (2010) Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell 143(4):617–627
Han DW, Greber B, Wu G, Tapia N, Araúzo-Bravo MJ, Ko K, Bernemann C, Stehling M, Schöler HR (2011) Direct reprogramming of fibroblasts into epiblast stem cell. Nat Cell Biol 13(1):66–71
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of affymetrix GeneChip probe level data. Nucleic Acids Res 31(4), e15
Kim JB, Sebastiano V, Wu G, Araúzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hübner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Schöler HR (2009) Oct4-induced pluripotency in adult neural stem cells. Cell 136(3):411–419
Ko K, Wu G, Araúzo-Bravo MJ, Kim J, Francine J, Greber B, Mühlisch J, Joo JY, Sabour D, Frühwald MC, Tapia N, Schöler HR (2011) Autologous pluripotent stem cells generated from adult mouse testicular biopsy. Stem Cell Rev 8(2):435–444
Ko K, Araúzo-Bravo MJ, Kim J, Stehling M, Schöler HR (2010) Conversion of adult mouse unipotent germline stem cells into pluripotent stem cells. Nat Protoc 5(5):921–928
Do JT, Joo JY, Han DW, Araúzo-Bravo MJ, Kim MJ, Greber B, Zaehres H, Sobek-Klocke I, Chung HM, Schöler HR (2009) Generation of parthenogenetic iPS cells from parthenogenetic neural stem cells. Stem Cells 27(12):2962–2968
Kim JB, Zaehres H, Araúzo-Bravo MJ, Schöler HR (2009) Generation of induced pluripotent stem cells from neural stem cells. Nat Protoc 4(10):1464–1470
Zaehres H, Kögler G, Araúzo-Bravo MJ, Bleidissel M, Santourlidis S, Weinhold S, Greber B, Kim JB, Buchheiser A, Liedtke S, Graffmann N, Zhao X, Meyer J, Reinhardt P, Burr B, Waclawczyk S, Ortmeier C, Uhrberg M, Schöler HR, Cantz T, Wernet P (2010) Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp Hematol 38(9):809–818
Conrad S, Renninger M, Hennenlotter J, Wiesner T, Just L, Bonin M, Aicher W, Bühring HJ, Mattheus U, Mack A, Wagner HJ, Minger S, Matzkies M, Reppel M, Hescheler J, Sievert KD, Stenz A, Skutella T (2008) Generation of pluripotent stem cells from adult human testis. Nature 456:344–349
Luu PL, Schöler HR, Araúzo-Bravo MJ (2013) Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs. Genome Res 23(12):2013–2029
Acknowledgments
This work has been supported by the Basque Country Foundation of Science (Ikerbasque).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Araúzo-Bravo, M.J. (2015). Computational Biology Methods for Characterization of Pluripotent Cells. In: Turksen, K., Nagy, A. (eds) Induced Pluripotent Stem (iPS) Cells. Methods in Molecular Biology, vol 1357. Humana Press, New York, NY. https://doi.org/10.1007/7651_2015_279
Download citation
DOI: https://doi.org/10.1007/7651_2015_279
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3054-8
Online ISBN: 978-1-4939-3055-5
eBook Packages: Springer Protocols